PIM1 is a serine/threonine kinase, the expression of which is controlled by the JAK/STAT pathway, and has also been associated with resistance to chemotherapy33–35 and molecularly targeted agents36,37 in several cancer types, but to our knowledge not previously for NB. Here, PIM1 is linked to neuroblastoma.